TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn’s disease in Europe
First allogeneic stem cell therapy to receive central marketing authorization approval in Europe
Alofisel offers a new treatment option for patients who d...
Continue Reading →
